Case Study: BlairBlair is a 22-year-old transgender female. As part of the medical treatments for transitioning, she is currently taking 17-beta estradiol and spironolactone (blocks androgen receptors...

1 answer below »

View more »
Answered Same DayOct 30, 2022

Answer To: Case Study: BlairBlair is a 22-year-old transgender female. As part of the medical treatments for...

Dr. Sulabh answered on Oct 31 2022
49 Votes
BLAIR CASE STUDY 6
Name of the Student
Name of the College or University
Name of the Course
Date
Assignment
1:
Blair is a transgender female
patient who is prescribed spironolactone medicine for blocking the secretion of the testosterone hormone along with the intake of 17-beta estradiol as a treatment therapy option. The prostate gland is present in the pelvic cavity of males. This gland is considered to be a male reproductive organ. In this case study, the patient is feeling like she is fainting after receiving female hormone therapy. The prostate gland secretes an alkaline fluid that maintains the viability of the sperm inside the vagina during sexual contact. The contraction of the muscles surrounding the prostate gland causes the release of semen during the process of ejaculation (Public Health, 1988). During the transition from male to female, the levels of testosterone will decrease in this patient and the alkaline secretion from the prostate gland will also decrease. Further, there is a secretion of the prostate-specific antigen from the prostate gland which is involved in decreasing the density and thickness of the semen. In addition, there is a conversion of the testosterone hormone to another metabolite named dihydrotestosterone inside the prostate gland cells. There is not much correlation in the levels of testosterone after the estradiol therapy (Leinung et al., 2018).
There is a homeostatic feedback loop of the secretion of testosterone from the Leydig cells in the testis. Spironolactone therapy given to this patient is important as this medicine blocks the secretion of testosterone thus reducing the development of the male secondary characteristics in this patient. The hypothalamus in the brain gets stimulated to release the gonadotropin-releasing hormone which activates the anterior pituitary gland to secrete the luteinizing hormone. The Leydig cells get stimulated to release testosterone which activates the secondary sexual characteristics. Further, the negative feedback loop causes the inhibition of the secretion of the luteinizing hormone from the anterior pituitary gland. One more loop causes the release of the follicle-stimulating hormone from the anterior pituitary gland which activates the Sertoli cells leading to the process of spermatogenesis (nd, 2018).
References
1. Institute for Quality and Efficiency in Health Care. (2016, August 23). How does the prostate work? Nih.gov; Institute for Quality and Efficiency in Health Care (IQWiG)....
SOLUTION.PDF

Answer To This Question Is Available To Download

Related Questions & Answers

More Questions »

Submit New Assignment

Copy and Paste Your Assignment Here
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
2025
2026
2027
SunMonTueWedThuFriSat
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
00:00
00:30
01:00
01:30
02:00
02:30
03:00
03:30
04:00
04:30
05:00
05:30
06:00
06:30
07:00
07:30
08:00
08:30
09:00
09:30
10:00
10:30
11:00
11:30
12:00
12:30
13:00
13:30
14:00
14:30
15:00
15:30
16:00
16:30
17:00
17:30
18:00
18:30
19:00
19:30
20:00
20:30
21:00
21:30
22:00
22:30
23:00
23:30